William Meury

Insider Reports History

Entity
Individual
Location
C/O Forest Laboratories, Inc., 909 Third Avenue, New York, NY
Signature
/s/ Jason Brown, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by William Meury:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Syndax Pharmaceuticals Inc Director Common Stock 65K $1.19M $18.27 Feb 7, 2024 Direct
Karuna Therapeutics, Inc. President and CEO, Director Common Stock 0 $0 $330.00 Mar 18, 2024 Direct
Karuna Therapeutics, Inc. President and CEO, Director Restricted Stock Units 0 $0 $330.00 Mar 18, 2024 Direct
Karuna Therapeutics, Inc. President and CEO, Director Option (right to buy) 0 $0 $136.81 Mar 18, 2024 Direct
Syndax Pharmaceuticals Inc Director Stock Options (Right to buy) 0 $25.84 Aug 2, 2023 Direct

Insider Reports Filed by William Meury

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KRTX Karuna Therapeutics, Inc. Mar 18, 2024 4 -$31.1M 4 Mar 18, 2024 President and CEO, Director
KRTX Karuna Therapeutics, Inc. Feb 13, 2024 1 $0 4 Feb 15, 2024 President and CEO, Director
SNDX Syndax Pharmaceuticals Inc Feb 7, 2024 1 $0 4 Feb 9, 2024 Director
KRTX Karuna Therapeutics, Inc. Dec 28, 2023 1 -$2.75M 4 Dec 29, 2023 President and CEO, Director
SNDX Syndax Pharmaceuticals Inc Aug 2, 2023 9 -$1.03M 4 Aug 3, 2023 Director
SNDX Syndax Pharmaceuticals Inc Feb 2, 2023 1 $0 4 Feb 3, 2023 Director
KRTX Karuna Therapeutics, Inc. Jan 3, 2023 2 $0 4 Jan 5, 2023 President and CEO, Director
KRTX Karuna Therapeutics, Inc. Jan 3, 2023 0 $0 3 Jan 5, 2023 President and CEO, Director
SNDX Syndax Pharmaceuticals Inc Feb 2, 2022 1 $0 4 Feb 3, 2022 Director